CDKN2A and cancer: Furthermore, the onset of cancer requires the presence of genetic alterations in key genes like TP53, CDKN2A, and SMAD4, which are responsible for encoding the tumor suppressor protein p53, cyclin-dependent kinase inhibitor 2A, and SMAD family member 4, respectively [5,6].